Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Lydia Greenlees"'
Autor:
Gemma Jones, Luis Vence, Patricia McCoon, Giulia Fabbri, Marta Milo, Douglas C Palmer, Radhika Rayanki, Tao Deng, Mohamed Moustafa, Sonia Iyer, Lydia Greenlees, Steve Arbitman, Arthur Lambert, Raffaello Cimbro
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/b41c22014c7b453db9b50256f924527e
Autor:
Philip M. Hemken, Nicolette M. Jeanblanc, Tracey Rae, Susan E. Brophy, Maria J. Datwyler, Ying Xu, T. Scott Manetz, Inna Vainshtein, Meina Liang, Xiaodong Xiao, Partha S. Chowdhury, Chien-ying Chang, Katie Streicher, Lydia Greenlees, Koustubh Ranade, Gerard J. Davis
Publikováno v:
Practical Laboratory Medicine, Vol 9, Iss , Pp 58-68 (2017)
Background: Dipeptidyl peptidase-4 (DPP-4) may be a suitable biomarker to identify people with severe asthma who have greater activation of the interleukin-13 (IL-13) pathway and may therefore benefit from IL-13-targeted treatments. We report the ana
Externí odkaz:
https://doaj.org/article/b5d2f2e9efc14bc1853381f654d6d33b
Autor:
Lydia Greenlees, Li Cheng, Bilal Omar, Yelena Lazdun, Jixin Wang, Fernanda Pilataxi, Michael Kuziora, Zachary Cooper, Luis Vence, Katie Streicher
Publikováno v:
Cancer Research. 82:3197-3197
Pancreatic cancer (PDAC) has the highest mortality rate of all major cancers, with few treatment options that provide long-term benefit to patients. Cancer associated fibroblasts (CAFs), the primary cellular component of the pancreatic tumor stroma,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbd54c3cb6f478c74edb13a9a569345e
https://doi.org/10.1158/1538-7445.am2022-3197
https://doi.org/10.1158/1538-7445.am2022-3197
Autor:
Fernanda Pilataxi, Lydia Greenlees, Li Cheng, Sriram Sridhar, Todd Creasy, Luis Vence, Katie Streicher
Publikováno v:
Cancer immunology, immunotherapy : CII. 71(5)
The rapid development of immune checkpoint blockade (ICB) therapies has revolutionized the cancer treatment landscape and brightened the long-term forecast for many cancer patients. However, the specific genomic and proteomic changes in tumors treate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18a1cd481faf8060f11ebb19106a20a7
https://pubmed.ncbi.nlm.nih.gov/34623465
https://pubmed.ncbi.nlm.nih.gov/34623465
Autor:
Emma Guttman-Yassky, Melissa Parker, Jingya Wang, Lydia Greenlees, Michael D. Howell, Mayte Suárez-Fariñas, Yeriel Estrada, Geoffrey L. Stephens, James G. Krueger
Publikováno v:
Clinical & Experimental Allergy. 47:1456-1467
Background Atopic dermatitis (AD), psoriasis (PS), and contact dermatitis (CD) are common skin diseases, characterized by barrier disruption and systemic inflammation, with unique epidermal signatures and common inflammatory pathways identified by tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9574376bb90128e1913f3397d3479703
https://doi.org/10.1111/cea.12979
https://doi.org/10.1111/cea.12979
Autor:
Jingya Wang, Alexandra Leonard, Michael D. Howell, Hao Liu, Roderick McPhee, Yeriel Estrada, Lydia Greenlees, Alexey Ruzin, Li Yu, Emma Guttman-Yassky
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 8:236-247.e3
Atopic dermatitis (AD) is a chronic inflammatory disease with significant local and systemic inflammation and barrier disruption. AD is associated with increased risk of allergen sensitization and skin colonization by Staphylococcus aureus. The heter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb63311591004718f4d94c00284c3704
https://doi.org/10.1016/j.jaip.2019.08.013
https://doi.org/10.1016/j.jaip.2019.08.013
Autor:
Wei Zhu, Meggan Czapiga, Brandon W. Higgs, Lydia Greenlees, Christopher Morehouse, Steven A. Greenberg, Anthony A. Amato, Laura Richman, Koustubh Ranade, Yihong Yao, Robert W. Georgantas, Bahija Jallal, Katie Streicher, Philip Brohawn
Publikováno v:
Arthritis & Rheumatology. 66:1022-1033
Objective The molecular basis of inflammatory myopathies such as dermatomyositis (DM), polymyositis, and inclusion body myositis, which share the characteristics of chronic muscle inflammation and skeletal muscle wasting, are poorly understood. As su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f025b486fa9bf670a421f3ef18bddaa
https://doi.org/10.1002/art.38292
https://doi.org/10.1002/art.38292
Autor:
Rajiv Raja, Jixin Wang, Han Si, Yashaswi Shrestha, Brandon W. Higgs, Rebecca Halpin, Qu Zhang, Lydia Greenlees, Ikbel Achour, Zachary A. Cooper, Maria Libera Ascierto, Katie Streicher, Shaad Essa Abdullah
Publikováno v:
Cancer Research. 79:3245-3245
Introduction: The role of CD8 cells in determining clinical outcome to programmed death ligand-1 (PD-L1) blocking treatments has been well characterized, however, the contribution of NK cells is not well understood. This is partly due to the paucity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::503c3c777da1823ca15eae93349c5dd8
https://doi.org/10.1158/1538-7445.am2019-3245
https://doi.org/10.1158/1538-7445.am2019-3245
Autor:
Gerard J. Davis, Reena Varkey, Ethan Grant, Meina Liang, Susan Brophy, Lydia Greenlees, Koustubh Ranade, Philip M. Hemken, T. Scott Manetz, Maria J. Datwyler, Nicolette M. Jeanblanc, Katie Streicher, Partha S. Chowdhury, Rozanne Lee
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 464
Periostin is being investigated as a potential biomarker for T-helper-2 (Th2)-driven asthma or eosinophilic inflammation and may help to identify patients more likely to benefit from interleukin-13-targeted treatments. We report the development and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75dc7f4cc1d77b72efd16a0e8f9c8256
https://pubmed.ncbi.nlm.nih.gov/27751727
https://pubmed.ncbi.nlm.nih.gov/27751727
Autor:
Brandon W. Higgs, Nicholas M. Durham, Fernanda Pilataxi, Li Cheng, Lydia Greenlees, Katie Streicher, Koustubh Ranade, Todd Creasy
Publikováno v:
Cancer Research. 78:1007-1007
Background Cancer cells utilize multiple mechanisms to suppress the development of an effective anti-tumor immune response. Overcoming these suppressive mechanisms to restore effector function to exhausted tumor infiltrating lymphocytes (TILs) is cri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e15b7d57ac054d69b23a1e697879186
https://doi.org/10.1158/1538-7445.am2018-1007
https://doi.org/10.1158/1538-7445.am2018-1007